Stock listing
ATOS Stock Price, News, Filings & Events — Atossa Therapeutics, Inc.
Selected listing: ATOS · BIVA · MXN · MX
This page tracks Atossa Therapeutics, Inc.'s ATOS:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATOS:BIVA. ATOS:BIVA is the stock-level entry point for investors researching Atossa Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Atossa Therapeutics, Inc. is a public company traded under the ticker ATOS in the American market. The company has a market capitalization of approximately $22.89 million. Atossa focuses on developing innovative therapeutics for breast cancer and other breast-related diseases.
- Ticker
- ATOS:BIVA
- Asset type
- Stock
- Market cap
- $25.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BIVA
- Currency
- MXN
Atossa Therapeutics, Inc. ATOS:BIVA stock context
This page tracks Atossa Therapeutics, Inc.'s ATOS:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATOS:BIVA. ATOS:BIVA is the stock-level entry point for investors researching Atossa Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Atossa Therapeutics, Inc. is a public company traded under the ticker ATOS in the American market. The company has a market capitalization of approximately $22.89 million. Atossa focuses on developing innovative therapeutics for breast cancer and other breast-related diseases.
Latest news from Atossa Therapeutics, Inc.
Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in ER-Positi...
July 28, 2026
Atossa Therapeutics Announces Presentation of Mechanism-Driven (Z)-Endoxifen Data in McCune-Albright Syndrome at AACR Special Conference ...
July 21, 2026
Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds
June 12, 2026
Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds
June 11, 2026
Atossa Therapeutics Announces ASCO 2026 Abstracts Highlighting (Z)-Endoxifen Activity Across ESR1 Mutations and Ongoing EVANGELINE Phase ...
May 27, 2026
Atossa Therapeutics, Inc. earnings calls
Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call
March 25, 2025 · Replay with transcript and chapters
Atossa Therapeutics, Inc. (ATOS) Q4 2023 Earnings Call
March 26, 2024 · Replay with transcript and chapters
Atossa Therapeutics, Inc. (ATOS) Q3 2023 Earnings Call
October 26, 2023 · Replay with transcript and chapters
Atossa Therapeutics, Inc. (ATOS) Q2 2023 Earnings Call
August 14, 2023 · Replay with transcript and chapters
Research Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for ATOS:BIVA.
Atossa Therapeutics, Inc. company profile
View the public company page for Atossa Therapeutics, Inc. on 6ix.
Atossa Therapeutics, Inc. news
Read company news and market updates connected to Atossa Therapeutics, Inc..
Atossa Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Atossa Therapeutics, Inc..
Alternate listings
ATOS:NASDAQ
US · USD
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
ATOS:BMV
MX · MXN
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
YAG:TRADEGATE
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
YAG:GETTEX
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
A2JJ99:LSX
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
ATOS:BOATS
US · USD
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
A2JJ99:LS
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
A41ZVB:LSX
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
YAG:DUS
DE · USD
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
YAG:FWB
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
A41ZVB:LS
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.
YAG:MUN
DE · EUR
Alternate listing for Atossa Therapeutics, Inc.; the primary context on this page is ATOS:BIVA.